News 2009
Below, please find a list of all LEO news from 2009.
Press releases
21-12-2009
Positive results for LEO Pharma’s phase III actinic (solar) keratosis trials on...
LEO Pharma today announced positive results for the company’s two Phase III actinic (solar) keratosis (AK) clinical trials using PEP005 (ingenol mebutate) Gel for the treatment of lesions on head treatment areas, which include the face and scalp. AK is a common pre-cancerous skin condition caused by sun exposure, which can develop into skin cancers if left untreated.
12-11-2009
LEO Pharma Completes Peplin Acquisition
Danish LEO Pharma has gained additional ground in the US after finalising the agreement to acquire Australian-US Peplin, Inc.
29-10-2009
World Psoriasis Day
World Psoriasis Day on October 29 is an annual day specially dedicated to people with psoriasis and psoriatic arthritis.
23-09-2009
LEO Pharma acquires own portfolio in the US
LEO Pharma A/S, a world leader in treatment of dermatological diseases, has re-acquired the US-rights to the company’s psoriasis portfolio and dermatology pipeline from the previous partner in the US, Warner Chilcott. The transaction sum is set at 1 billion USD.
03-09-2009
LEO Pharma to Acquire Peplin for US$287.5m
Peplin, Inc. today announced a definitive merger agreement whereby LEO Pharma A/S (LEO), a privately-held, leading global pharmaceutical company within Dermatology and Critical Care, will acquire all outstanding securities of Peplin for approximately US$287.5 million (currently A$348.4 million) in cash. This represents a purchase price of US$16.99 per common share of Peplin stock or A$1.03 per Peplin CHESS Depositary Interest (CDI). US/AUS exchange rate of 1.21 as at 2 September 2009.
04-06-2009
LEO Pharma to expand in Russian market
LEO Pharma and Nycomed conclude new marketing agreement in Russia.
27-03-2009
2008 record financial statements from LEO Pharma
After a record year with strong sales growth for Daivobet® and Innohep®, LEO Pharma is investing in emerging markets, for example China and Mexico, as well as in making more progress in its strong R&D pipeline.
28-01-2009
LEO Pharma wins a litigation with generic drug manufacturer Kotra Pharma in Malaysia
LEO Pharmaceutical Products Ltd A/S or LEO Pharma a global and leading pharmaceutical company from Denmark have on 13 January 2009 secured a decisive judgment against a generic drugs manufacturer in Malaysia after a lengthy trial.
